Cyclic amide derivatives, and their production and use as antithrombotic agents

Details for Australian Patent Application No. 2005245298 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Kubo, Keiji; Imaeda, Yasuhiro

Agent Griffith Hack

Pub. Number AU-B-2005245298

PCT Pub. Number WO2005/113504

Priority 2004-152000 21.05.04 JP

Filing date 20 May 2005

Wipo publication date 1 December 2005

Acceptance publication date 7 April 2011

International Classifications

C07D 211/76 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/113504 Priority application(s): WO2005/113504

7 April 2011 Application Accepted

  Published as AU-B-2005245298

4 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005245323-Multi-compartment container

2005245296-Stable crystal of 4-oxoquinoline compound